Harbour BioMed Public Relations
E-mail: pr@harbourbiomed.com
SHANGHAI – Newly founded biopharma Harbour Biomed Therapeutics Ltd., of Shanghai, has acquired privately held Harbour Antibody BV, of Cambridge, Mass. The cash-and-equity deal was inked after Harbour Biomed secured $50 million in venture financing from life science investors Adventech and Legend.
Harbour BioMed Public Relations
E-mail: pr@harbourbiomed.com